((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate-13C9,15N3 (sodium)

CAT:

804-HY-W011090S

Size:

1 mg

Price:

Ask

For price, please contact [email protected]

UNSPSC Description: ((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate-13C9,15N3 (sodium) is the 13C and 15N labeled Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate[1].
Target Antigen: Isotope-Labeled Compounds
Type: Isotope-Labeled Compounds
Related Pathways: Others
Field of Research: Others
Assay Protocol: https://www.medchemexpress.com/2r-3s-4r-5r-5-4-amino-2-oxopyrimidin-1-2h-yl-3-4-dihydroxytetrahydrofuran-2-yl-methyl-phosphate-13c9-15n3-sodium.html
Solubility: 10 mM in DMSO
Smiles: O=P(O[Na])(O[Na])O[13CH2][13C@@]1(O[13C@]([H])([15N]2[13CH]=[13CH][13C]([15NH2])=[15N][13C]2=O)[13C]([H])([13C@@]1(O)[H])O)[H]
Molecular Weight: 379.07
References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
Shipping Conditions: Room temperature
Clinical Information: No Development Reported

Cat	Name
HY-W011090S	((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate-13C9,15N3 (sodium)
HY-146708S	((2R,3S,4R,5R)-5-(2-Amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate-15N4 (sodium)
HY-402383-02	O-(((2R,3S,5R)-5-(5-Bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl) O,S-dihydrogen phosphorothioate
HY-402383-01	O-(((2R,3S,5R)-5-(5-Bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl) O,S-dihydrogen phosphorothioate
HY-W048245	(2R,3S,4R)-2-(Hydroxymethyl)tetrahydrothiophene-3,4-diol
HY-14664C-03	(3S,5R)-Fluvastatin (sodium)
HY-14664C-02	(3S,5R)-Fluvastatin (sodium)
HY-14664C-01	(3S,5R)-Fluvastatin (sodium)
HY-20838B-02	(S)-2-Amino-2-(tetrahydro-2H-pyran-4-yl)ethanoic acid
HY-20838A-05	(R)-2-Amino-2-(tetrahydro-2H-pyran-4-yl)acetic acid

Cat	Name
TRC-A213340-100MG	((2S,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, sodium salt
TRC-B571655-500MG	((2R,3S,4R,5R)-5-(4-(Benzyloxy)-2-oxopyridin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl Dihydrogen Phosphate
OR1014927-01	Sodium ((2R,3S,5R)-5-(4-Amino-2-Oxopyrimidin-1(2H)-Yl)-3-Hydroxytetrahydrofuran-2-Yl)Methyl Phosphate
OR1014927-02	Sodium ((2R,3S,5R)-5-(4-Amino-2-Oxopyrimidin-1(2H)-Yl)-3-Hydroxytetrahydrofuran-2-Yl)Methyl Phosphate
OR1014927-04	Sodium ((2R,3S,5R)-5-(4-Amino-2-Oxopyrimidin-1(2H)-Yl)-3-Hydroxytetrahydrofuran-2-Yl)Methyl Phosphate
OR1014927-03	Sodium ((2R,3S,5R)-5-(4-Amino-2-Oxopyrimidin-1(2H)-Yl)-3-Hydroxytetrahydrofuran-2-Yl)Methyl Phosphate
TRC-A417762-25MG	((2S,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl-2-13C-1,3-15N2)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, sodium salt
TRC-A619190-100MG	((2R,3S,4R,5R)-5-(4-Amino-2-oxo-1,3,5-triazin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl Formate
TRC-B571650-500MG	((2R,3S,4R,5R)-5-(4-(Benzyloxy)-2-oxopyridin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl bis(2-cyanoethyl) Phosphate
TRC-B245950-25MG	((2R,3S,4R,5R)-5-(6-(Benzylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl Dihydrogen Phosphate